5.040USD-3.26%Mkt Cap: 4.96M $P/E: 0.022d ago
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persi…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap4.96M $
Enterprise Value19.57M $
Revenue (TTM)7.69M $
Gross Profit252.00K $
Net Income (TTM)-33.25M $
Revenue/Share14.43 USD
Last Price5.040 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees54
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS08862L1035
Valuation
P/E (Trailing)0.02
P/E (Forward)-3.11
PEG—
EV/EBITDA-0.79
EV/Revenue2.55
P/S0.66
P/B0.50
EPS (TTM)313.81
EPS (Forward)-1.66
52W Range
4.8800% of range95.60
52W High95.60 USD
52W Low4.880 USD
Profitability
Gross Margin3.28%
Oper. Margin-373.98%
EBITDA Margin0.00%
Profit Margin-432.99%
ROE-542.75%
ROA-93.96%
Growth
Revenue Growth0.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.14M $
CapEx (TTM)1.02M $
FCF Margin-168.34%
FCF Yield-260.82%
Net Debt13.79M $
Net Debt/EBITDA-0.56
Balance Sheet
Debt/Equity3.82
Current Ratio3.31
Quick Ratio1.59
Book Value/Sh10.39 USD
Cash/Share10.25 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 10, 2017
Splits
Last Split1:20
Split DateJul 13, 2026
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)30.00 USD
Upside (mean)+495.2%
Target Range30.00 USD – 30.00 USD
# Analysts1
Ownership
Shares Out.984.41K
Float813.51K
Insiders11.54%
Institutions7.19%
Short Interest
Short Ratio1.3d
Short % Float2.61%
Short % Out.2.58%
Shares Short22.87K
Short (prev mo.)16.59K
Technical
SMA 506.894 (-26.9%)
SMA 20015.73 (-68.0%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)40.64K
Avg Vol (10d)34.31K
Technical Indicators
RSI (14)39.3
MACD-0.3617
MACD Signal-0.4169
MACD Hist.+0.0552
BB Upper6.623 USD
BB Middle5.653 USD
BB Lower4.684 USD
BB Width34.29%
ATR (14)0.7507 USD
Vol Ratio (20d)0.49x